OCT West Coast: Covid-19’s impact on clinical trials
In these unprecedented times, with the world gripped by the Covid-19 pandemic, all eyes are on Big Pharma to find…
Latest Analysis
-
2 hours
-
9 hours
-
4 days
-
5 days
-
2 hours
-
9 hours
-
4 days
-
5 days
OCT West Coast: key points on engaging patients and advocacy groups
Bringing power to the patient in all areas of healthcare and research has become one of the fastest growing concepts…
Latest News
View More
Veru to progress Covid-19 drug into Phase III study
Veru is all set to advance its drug, VERU-111, into a Phase III registration clinical study in hospitalised high-risk Covid-19 patients on obtaining clinically meaningful…
OCT West Coast: key points on engaging patients and advocacy groups
Bringing power to the patient in all areas of healthcare and research has become one of the fastest growing concepts and conversations amongst industry leaders…
Sinopharm seeks EUA for Covid-19 vaccines in Philippines
Chinese company Sinopharm has submitted an application to the Food and Drug Administration (FDA) of the Philippines for emergency use…
AstraZeneca’s antibody reduces exacerbation rates in asthma trial
AstraZeneca has reported positive full results from the pivotal Phase III NAVIGATOR trial of human monoclonal antibody tezepelumab which showed…
Medable to integrate Seqster technology in decentralised trial platform
Medable has collaborated with healthcare technology company Seqster to integrate real-world patient data streams in decentralised clinical trials platform. Seqster…
Innovent doses first patient in US trial of advanced malignancy treatment
Innovent Biologics has dosed the first subject in a Phase Ia clinical trial of a potential recombinant anti-CD47/PD-L1 bispecific antibody…
Company A-Z
View More
VaLea Clinical Trials
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
Latest Content
View More
T1Detect screening could have lasting effects on T1D awareness and management
On 8 December, the Juvenile Diabetes Research Foundation (JDRF) announced the launch of their groundbreaking screening initiative for type 1…
Ongoing disrupted clinical trials due to Covid-19
As the Covid-19 pandemic continues into the last month of the year, the numbers of confirmed cases and deaths continue…
UKONIQ™ (umbralisib) for the Treatment of Marginal Zone Lymphoma (MZL) and Follicular Lymphoma (FL)
UKONIQ™ (umbralisib) is the first and only oral, dual inhibitor of phosphoinositide 3 kinase (PI3K) delta and casein kinase 1…
New Warehouse Construction at Staufen Headquarters
In the past few months, two new warehouses were erected and put into operation on the IKA premises. IKA continues…
The Complete Guide to Freelancers in MedTech
The global MedTech outsourcing market has ballooned as businesses look for ways to improve patient care while streamlining their own…